+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Sweden Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 4997298
  • Report
  • January 2022
  • Region: Sweden
  • 70 Pages
  • Mordor Intelligence

The market for respiratory devices has been increasing in Sweden primarily due to increasing prevalence of respiratory disorders, such as COPD, TB, Asthma, and Sleep Apnea. The prevalence of chronic obstructive pulmonary disease (COPD) in the adult population in Sweden is approximately 10%, according to Josefin Sundh et al., published in European Clinical Respiratory Journal 2017. This has been the primary reason for the growth in demand for respiratory devices in Sweden.

Owing to the rapid advancements, the population has been benefited with the new technologies which are more effective. This has propelled the growth of the market even further. However, the high cost of devices and instruments has been restraining the market growth.

Key Market Trends

Inhalers as Therapeutic devices are expected to Register High Growth in the Forecast Period

As per the report by Eivind Borna et al., published in European Journal of Allergy and Clinical Immunology 2019, the prevalence of reported ever asthma, physician‐diagnosed asthma, use of asthma medication, and current asthma has increased significantly from 9.6% to 11%, 8.3% to 10%, 8.6% to 9.8%, and 8.1% to 9.1%, respectively, between 2008 and 2016. There are also increase in the prevalence of respiratory symptoms during the same period.

Inhalers are very common among asthma patients as a delivery method. Asthma inhalers are hand-held, portable devices that deliver medication to your lungs. A variety of asthma inhalers are available to help control the asthma symptoms. Hence as the prevalence of asthma increases in Sweden, the demand for inhalers is also expected to increase as well. This is expected to help the market growth in the region.

Competitive Landscape

Sweden is a developed country with well-structured healthcare system in the country. As a result, many global players in the respiratory devices market are present in the country. Moreover, some domestic players like Breas Medical (now a subsidiary of Fosun Pharmaceutical) have also been competing in the Sweden market. These factors have made the region very competitive.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices CPAP Devices Humidifiers Nebulizers Ventilators Inhalers Other Therapeutic Devices
5.1.3 By Disposables
6.1 Company Profiles
6.1.1 Dragerwerk AG
6.1.2 Fisher & Paykel Healthcare Ltd
6.1.3 Fosun Pharmaceutical (Breas Medical AB)
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Invacare Corporation
6.1.7 Koninklijke Philips NV
6.1.8 Medtronic PLC
6.1.9 Smiths Medical Inc
Note: Product cover images may vary from those shown